Cytotherapy

Cytotherapy represents a promising avenue in cancer research, leveraging the body's own cells to combat the disease. This innovative approach involves harnessing the power of immune cells, such as T cells, to target and destroy cancerous cells. One notable technique is CAR-T cell therapy, where T cells are genetically modified to express chimeric antigen receptors (CARs) that recognize specific proteins on cancer cells. Upon infusion back into the patient, these engineered T cells can effectively seek out and eliminate tumors.

Moreover, cytotherapy extends beyond CAR-T cells, encompassing various strategies like dendritic cell vaccines and natural killer (NK) cell therapy. These therapies hold immense potential for personalized cancer treatment, offering tailored solutions based on individual immune profiles. As research progresses, cytotherapy continues to evolve, bringing hope for more effective and targeted cancer therapies with potentially fewer side effects.